Niclosamide treatment limited the invasion and migration of UM cells, decreased MMP-9 protein expression, and suppressed the NF-κB and Wnt/β-catenin signaling pathways, indicating its strong anti-cancer properties [215]. This evidence concerns the gene MMP9 and cancer.